Repros Therapeutics Inc (RPRX)

[io_io]

<I think some are confusing this point with companies that clearly manipulate the press on trials, and the pushback on that.>

I agree. Most biotech CEOs have to mis-lead to the extent they can get away with.

Still, very few bemoan their bad luck due to a lack of trial design power - which they could easily do (blame it on the consultant, or on withdrawals, etc).